G

Glyphic Biotechnologies

Next-generation protein sequencing platform provider

Staff / Senior Scientist - Bioconjugation Chemistry

Biology & BiotechConfirmed live in the last 24 hours
Full-timeBerkeley, CA, USA

About the Job

Requirements

  • A Master of Science or PhD in organic chemistry, chemical biology, biochemistry, or a related field.
  • Industry experience in bioconjugation chemistry and the ability to independently design, develop, and troubleshoot conjugation workflows.
  • For Staff Scientist: an MS with 8 or more years of experience or a PhD with 6 or more years of experience; for Senior Scientist: an MS with 6 or more years of experience or a PhD with 4 or more years of experience.
  • Deep expertise in protein and/or peptide bioconjugation, including NHS esters, maleimides, click chemistries (CuAAC, SPAAC, IEDDA), isothiocyanate coupling, and related bioorthogonal approaches.
  • Experience with site-specific amino acid sidechain chemistry beyond maleimide chemistry, such as Cys, Lys, Arg, Tyr, Trp, or Asp/Glu, for multistep workflows.
  • A track record of developing novel blocking groups and conducting structure-activity relationship studies to optimize blocking-group performance and selectivity.
  • Proficiency in analytical characterization, including HPLC method development, LC-MS/MS for conjugate analysis, UV/Vis, and CE.
  • A method-development mindset and a history of building and adapting new chemical approaches rather than executing established protocols.
  • Ability to function as an independent contributor and collaborative partner in a cross-functional team setting.

Responsibilities

  • Partner with sample preparation and assay development teams to screen and select conjugation chemistries for peptides and oligonucleotides that enable single-molecule protein sequencing.
  • Design bioconjugation workflows using NHS-ester chemistry, maleimides, isothiocyanate chemistry, and click chemistry (CuAAC, SPAAC, IEDDA).
  • Prepare bioconjugation reagents to enable studies from proof-of-concept through prototype kitting.
  • Develop labeling strategies based on Edman chemistry.
  • Develop and apply selective C-terminal and N-terminal conjugation chemistries.
  • Develop site-specific labeling strategies for amino acid sidechains (Cys, Lys, Arg, Tyr, Trp, His, Asp/Glu) on native peptides, and screen protecting groups to enhance amino acid signal in the protein sequencing assay.
  • Enable on-bead workflows to label and release peptides for interrogation in the sequencing assay.
  • Synthesize and purify peptide and oligonucleotide conjugates for assay testing.
  • Characterize conjugation efficiency, purity, and stability using HPLC, LC-MS/MS, NMR, CE, UV/Vis, and FTIR.
  • Scale conjugate synthesis from R&D quantities to prototype-grade supply for internal testing, attending to reproducibility, shelf life, and fit-for-purpose quality.
  • Work cross-functionally with sample preparation, assay integration, and reagent manufacturing teams to troubleshoot conjugation failures and optimize workflows.
  • Contribute to intellectual property development through invention disclosures.
  • Maintain rigorous experimental documentation in Confluence and laboratory notebooks, and author and maintain SOPs for new conjugation methods.

Desired Qualifications

  • Hands-on experience with solid-phase peptide synthesis (SPPS), including protecting-group strategies beyond standard Fmoc/Boc and selective on-resin modifications.
  • Experience with peptide C-terminal chemistry manipulation methods, such as thioester formation, native chemical ligation, or photoredox/iridium-catalyzed C-terminal labeling.
  • Familiarity with oligonucleotide chemistry and oligo-conjugation techniques, including ITC, phosphoramidite modifications, and click coupling to nucleic acids.
  • Experience with scalable surface chemistry methods for flow cells or solid-phase supports.
  • Familiarity with statistical and design-of-experiments-based experimental design for chemistry optimization.
  • Prior experience in an early-stage biotech or tools/diagnostics company.

About the Company

Glyphic Biotechnologies

Next-generation protein sequencing platform provider

Glyphic Biotechnologies is advancing proteomics by building a next-generation protein sequencing platform. The core product is designed to reveal detailed information about proteins, helping researchers and medical institutions gain new insights into biology and disease. The platform supports sequencing services for researchers and may be licensed to other organizations, generating revenue from service fees and licensing agreements. Unlike many competitors that focus on smaller-scale tools, Glyphic emphasizes a first-of-its-kind sequencing capability for proteins, along with diverse deployment options (serving research labs directly and via licensing). The company's goal is to enable deeper understanding of bodily functions through protein data and to bring its sequencing technology to broader use in the life sciences through services and licensing deals.

Company size
11-50
Company stage
Early VC
Total funding
$43M
Headquarters
Berkeley, CA
Founded
2021

Recently Posted Jobs

Explore more opportunities at Glyphic Biotechnologies

See more jobs